Semax

Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) that enhances cognitive function by increasing brain-derived neurotrophic factor (BDNF) and modulating neurotransmitter activity. This nootropic peptide supports neuroplasticity, memory formation, and stress recovery through its interaction with melanocortin receptors.

Category: Compound Evidence: 6/10 Tier: Tier 3 (preliminary)

Origin & History

Semax is a synthetic peptide derived from adrenocorticotropic hormone (ACTH). It was developed in Russia and is synthesized using peptide synthesis techniques. Semax is primarily used for its nootropic and neuroprotective properties.

Historical & Cultural Context

Developed in Russia in the 1980s, Semax is used in Eastern Europe for cognitive enhancement and neuroprotection.

Health Benefits

- Enhances cognitive function and memory by increasing brain-derived neurotrophic factor (BDNF), supporting neuroplasticity and learning. - Reduces symptoms of anxiety and depression by modulating neurotransmitter levels, including serotonin and dopamine. - Accelerates mental recovery after stress or brain injury by promoting neuroprotection and reducing oxidative stress. - Improves attention span and focus by stimulating the prefrontal cortex, leading to better executive function. - Boosts mental energy and alertness by increasing cerebral blood flow and oxygenation. - Supports mood stabilization through regulation of the hypothalamic-pituitary-adrenal (HPA) axis. - May enhance long-term memory retention by up to 30% in clinical studies, making it valuable for students and professionals. - Offers neuroprotective effects against age-related cognitive decline by reducing inflammation and supporting synaptic health.

How It Works

Semax activates melanocortin MC4 receptors and increases expression of brain-derived neurotrophic factor (BDNF), promoting neuroplasticity and synaptic strength. The peptide modulates dopaminergic and serotonergic neurotransmission while enhancing acetylcholine release in the hippocampus. It also activates the PI3K/Akt signaling pathway, supporting neuronal survival and growth.

Scientific Research

Semax has been studied in animal models and limited human trials, showing potential cognitive and neuroprotective benefits. More extensive clinical trials are needed.

Clinical Summary

Human studies with 50-100 participants show Semax improves cognitive performance scores by 15-25% compared to placebo when administered nasally at 600-900 mcg daily. Clinical trials demonstrate significant reductions in anxiety and depression ratings after 10-14 days of treatment. Research evidence comes primarily from Eastern European studies, with some methodological limitations and need for larger Western clinical trials for regulatory approval.

Nutritional Profile

- Composed of a sequence of amino acids.
- Administered as a nasal spray for direct brain delivery.
- Non-toxic and well-tolerated in studied doses.

Preparation & Dosage

Typical dosage ranges from 300 mcg to 3 mg per day, administered nasally. Consult a healthcare provider before use.

Synergy & Pairings

Bacopa Monnieri, Omega-3, Phosphatidylserine

Safety & Interactions

Semax appears well-tolerated with mild side effects including nasal irritation, headache, and occasional dizziness when administered intranasally. No significant drug interactions have been reported, though it may theoretically enhance effects of other cognitive enhancers or antidepressants. Safety during pregnancy and breastfeeding is unknown, so use should be avoided. Individuals with severe psychiatric conditions should consult healthcare providers before use.